1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow DEAE-Dextran: new trials by email Literature Review of DEAE-Dextran trials Research Report on DEAE-Dextran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma Best Supportive Care (BSC), Personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) - Hepatocellular Carcinoma (HCC) | Phase 3 | Not yet recruiting | University Health Network, Toronto | 60 | 2026-12-01 | 2026-10-26 |
University Health Network, Toronto (1)
Canada (1)